Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88123155ca8a10bccbe8ca81c45812e2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-603 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-606 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-603 |
filingDate |
2013-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b9ec58d2254e81ccd204cb996cb0226 |
publicationDate |
2015-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2870966-A1 |
titleOfInvention |
Salicylates for use in the treatment of cancer |
abstract |
The present invention relates to a dosage regimen of salicylates (ASA/diflunisal combined with at least two different salicylates selected from ASA/ 4-aminosalicylic acid and diflunisal) for use in the treatment of cancer. |
priorityDate |
2013-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |